Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Foteini Theodorakakou

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
JACC. Cardiooncology|March 6, 2023
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewGeorgios Georgiopoulos, Nikolaos Makris, Ageliki Laina, et al.
European Heart Journal. Cardiovascular Imaging|December 24, 2023
Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosisAlexandros Briasoulis, Dimitrios Bampatsias, Ioannis Petropoulos, et al.
Current Problems in Cardiology|January 19, 2026
Impact of Disease-Modifying Therapies on Imaging Parameters in Cardiac Amyloidosis: A Systematic Review and Meta-AnalysisAlexandros Briasoulis, Georgios Georgiopoulos, Christos Kourek, et al.
Journal of Clinical Medicine|September 23, 2022
Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging ParametersAlexandros Briasoulis, Foteini Theodorakakou, Athanasios Rempakos, et al.
Proteomics|May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple MyelomaMaria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2026
Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell TherapyAlexandros Briasoulis, Niki Lama, Angelos Soranidis, et al.
Insights Into Imaging|March 29, 2022
The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosisNiki Lama, Alexandros Briasoulis, Efstratios Karavasilis, et al.
Cancers|March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World StudyEyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
Hematological Oncology|March 28, 2023
Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B diseaseFoteini Theodorakakou, Alexandros Briasoulis, Despina Fotiou, et al.
Ejhaem|January 27, 2025
Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
JACC. Cardiooncology|March 6, 2023
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewGeorgios Georgiopoulos, Nikolaos Makris, Ageliki Laina, et al.
European Heart Journal. Cardiovascular Imaging|December 24, 2023
Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosisAlexandros Briasoulis, Dimitrios Bampatsias, Ioannis Petropoulos, et al.
Current Problems in Cardiology|January 19, 2026
Impact of Disease-Modifying Therapies on Imaging Parameters in Cardiac Amyloidosis: A Systematic Review and Meta-AnalysisAlexandros Briasoulis, Georgios Georgiopoulos, Christos Kourek, et al.
Journal of Clinical Medicine|September 23, 2022
Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging ParametersAlexandros Briasoulis, Foteini Theodorakakou, Athanasios Rempakos, et al.
Proteomics|May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple MyelomaMaria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2026
Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell TherapyAlexandros Briasoulis, Niki Lama, Angelos Soranidis, et al.
Insights Into Imaging|March 29, 2022
The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosisNiki Lama, Alexandros Briasoulis, Efstratios Karavasilis, et al.
Cancers|March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World StudyEyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
Hematological Oncology|March 28, 2023
Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B diseaseFoteini Theodorakakou, Alexandros Briasoulis, Despina Fotiou, et al.
Ejhaem|January 27, 2025
Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Pageof 8